Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:47 PM
Ignite Modification Date:
2025-12-24 @ 12:47 PM
NCT ID:
NCT00167661
Eligibility Criteria:
Inclusion Criteria:
* Participants must be a single-organ recipient (kidney only)
* Participants who are receiving their first living donor or deceased donor transplant
Exclusion Criteria:
* Participants who are recipients of HLA-identical living-donor renal transplants
* Participants with a PRA value \> 10% within 30 days prior to the transplant
* Participants who have received a multi-organ transplant
* Participants who are who are positive for hepatitis C, hepatitis B surface antigen or HIV
* Participants who have received an investigational drug within 6 weeks of study entry
* Participants who have a previous history of, or who currently have, malignancies and/or lymphoma
* Participants who have received corticosteroids within three months of transplantation
* Participants who are 3rd transplant recipients
* Female participants who are pregnant or lactating. Fertile female participants who are sexually active must agree to use an acceptable method of birth control during the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Months
Maximum Age:
18 Years
Study:
NCT00167661
Study Brief:
Protocol Section:
NCT00167661